GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Margin of Safety % (DCF FCF Based)

Kangstem Biotech Co (XKRX:217730) Margin of Safety % (DCF FCF Based) : N/A (As of Apr. 29, 2025)


View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Kangstem Biotech Co's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

Competitive Comparison of Kangstem Biotech Co's Margin of Safety % (DCF FCF Based)

For the Biotechnology subindustry, Kangstem Biotech Co's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kangstem Biotech Co's Margin of Safety % (DCF FCF Based) Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kangstem Biotech Co's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Kangstem Biotech Co's Margin of Safety % (DCF FCF Based) falls into.


;
;

Kangstem Biotech Co Margin of Safety % (DCF FCF Based) Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Margin of Safety % (DCF FCF Based) provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangstem Biotech Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Margin of Safety % (DCF FCF Based)
Comparable Companies
XKRX:214260 XKRX:278650 XKRX:048530 XKRX:311690 XKRX:234690 XKRX:376270 XKRX:251120 XKRX:084990 XKRX:456070 XKRX:217950 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR
Website
http://www.kangstem.com
Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines